Kayla Sage

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 125 citations · Full text

Medicine, Neurology, Cerebrovascular Surgery +11

Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis

Thalia S. Field, Vanessa Dizonno, Mohammed Almekhlafi et al. · Stroke · 2023 · 71 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Hydroxychloroquine for Primary Progressive Multiple Sclerosis

Marcus Koch, Sharanjit Kaur, Kayla Sage et al. · Annals of Neurology · 2021 · 42 citations

Medicine, Neurology, Pharmacotherapy +17

Repurposing Domperidone in Secondary Progressive Multiple Sclerosis

Marcus Koch, Kayla Sage, Sharanjit Kaur et al. · Neurology · 2021 · 22 citations

Health Professions, Critical Care Nursing, Health Sciences +13